Adenocarcinoma of the lung in Down syndrome: First clinical report

Tumori

Volumn 99, Issue 4, 2013, Pages

  Satgé, Daniel ^a   Salmeron, Sergio ^b   Homsi, Toufik ^b   Réthoré, Marie Odile ^c   Tredaniel, Jean ^b  

^a CENTRE HOSPITALIER   (France)

^b SAINT JOSEPH HOSPITAL   (France)

^c Institut Jerome Lejeune   (France)

Author keywords

Delayed diagnosis; Down syndrome; Intellectual disability; Lung carcinoma; Second malignancy

Indexed keywords

DAUNORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CASE REPORT; DOWN SYNDROME; DYSPNEA; HEMIPLEGIA; HUMAN; HUMAN TISSUE; HUMERUS FRACTURE; LUNG ADENOCARCINOMA; MALE; MEDIASTINUM METASTASIS; SKULL IRRADIATION; VARICOSIS;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD, PRESCHOOL; DOWN SYNDROME; DRUG RESISTANCE, NEOPLASM; FATAL OUTCOME; HUMANS; INTELLECTUAL DISABILITY; LUNG NEOPLASMS; MALE; PALLIATIVE CARE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; QUINAZOLINES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84890887380     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161309900427     Document Type: Article

References (19)

1. Satgé D, Sommelet D, Geneix A, Nishi M, Malet P, Vekemans MJ: A tumor profile in Down syndrome. Am J Med Genet, 78: 207-216, 1998.
2. Patja K, Eero P, Iivanainen M: Cancer incidence among people with intellectual disability. J Intellect Disabil Res, 45: 300-307, 2001.
3. Sullivan SG, Hussain R, Threlfall T, Bittles AH: The incidence of cancer in people with intellectual disabilities. Cancer Causes Control, 15: 1021-1025, 2004.
4. Satgé D, Sasco AJ, Azema B, Culine S: Cancers in persons with intellectual deficiency: current data. In: Mental retardation research focus, Charleton NV (Ed), pp 47-84, Nova Sciences Publisher, New York, 2007.
5. Hasle H, Clemmensen IH, Mikkelsen M: Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet, 355: 165-169, 2000.
6. Patja K, Pukkala E, Sund R, Iivanainen M, Kaski M: Cancer incidence of persons with Down syndrome in Finland: a population-based study. Int J Cancer, 118: 1769-1772, 2006.
7. Sullivan SG, Hussain R, Glasson EJ, Bittles AH: The profile and incidence of cancer in Down syndrome. J Intel Disab Res, 51: 228-231, 2007.
8. Scholl T, Stein Z, Hansen H: Leukemia and other cancers, anomalies and infections as causes of death in Down's syndrome in the United States during 1976. Dev Med Child Neurol, 24: 817-829, 1982.
9. Sasco AJ, Day SM, Voirin N, Strauss DJ, Shavelle RM, Satgé D: Cancer mortality in Down syndrome in California. Int J Disabil Hum Dev, 7: 413-424, 2008.
10. Tracy J, Hosken R: The importance of smoking education and preventative health strategies for people with intellectual disability. J Intel Disabil Res, 41: 416-421, 1997.
11. Kohno T, Kawanishi M, Matsuda S, Ichikawa H, Takada M, Ohki M, Yamamoto T, Yokota J: Homozygous deletion and frequent allelic loss of the 21q11.1-q21.1 region including the ANA gene in human lung carcinoma. Genes Chromosomes Cancer, 21: 236-243, 1998.
12. Yamada H, Yanagisawa K, Tokumaru S, Taguchi A, Nimura Y, Osada H, Nagino M, Takahashi T: Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11-21 in human lung cancer. Genes Chromosomes Cancer, 47: 810-818, 2008.
13. Slavc I, Urban C, Haas OA, Kroisel PM, Koller U: Acute megakaryocytic leukaemia in children. Clinical, immunologic, and cytogenetic findings in two patients. Cancer, 68: 2266-2272, 1991.
14. Zagzag D, Miller DC, Cangiarella J, Allen JC, Greco MA: Brainstem glioma after radiation therapy for acute myeloblastic leukaemia in a child with Down syndrome. Possible pathogenetic mechanisms. Cancer, 70: 1188-1193, 1992.
15. Yamamoto Y, Sakaritani N, Kadowaki H, Miyagawa I: Bilateral testicular tumors associated with Down syndrome. Jpn J Urol Surg, 7: 801-802, 1994.
16. Rosso P, Terracini B, Fears TR, Jankovic M, Fossati Bellani F, Arrighini A, Carli M, Cordero di Montezemolo L, Garrè ML, Guazzelli C, Izzi G, Loiacono G, Mancini A, Tamaro P, Testi AM, Masera G, Haupt R: Second malignant tumors after elective end of therapy for a first cancer in childhood: a multicenter study in Italy. Int J Cancer, 59: 451-456, 1994.
17. Meadows AT: Second tumours. Eur J Cancer, 37: 2074-2079, 2001.
18. Kastner T, Nathanson R, Friedman DL: Mortality among individuals with mental retardation living in the community. Am J Ment Retard, 98: 285-292, 1993.
19. Tuffrey-Wijne I, Bernal J, Hubert J, Butler G, Hollins S: People with learning disabilities who have cancer: an ethnographic study. Br J Gen Pract, 59: 503-509, 2009.